Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 100

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 100
---
decrease) in the assumed initial public offering price of $11.00 per
Ordinary Share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) our
pro forma as adjusted net tangible book value as of June 30, 2024 after this offering by approximately $0.06 per Ordinary Share,
and would increase (decrease) dilution to investors in this offering by $0.19 per Ordinary Share, assuming that the number of Ordinary
Share offered by us, as set forth on the cover page of this prospectus, remains the same, after deducting the estimated underwriting discounts
and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of Ordinary Shares we are offering.
An increase (decrease) of 100,000 in the number of Ordinary Shares we are offering would increase (decrease) our pro forma as adjusted
net tangible book value as of June 30, 2024 after this offering by approximately $0.19 per Ordinary Share, and would decrease (increase)
dilution to investors in this offering by approximately $0.19 per Ordinary Share, assuming the assumed initial public offering price
per Ordinary Share remains the same, after deducting the estimated underwriting discounts and commissions and estimated offering expenses
payable by us.

If the underwriters exercise
in full their option to purchase additional Ordinary Shares and/or additional Warrants, the pro forma as adjusted net tangible book value
will increase to $1.76 per Ordinary Share, representing an immediate increase in pro forma as adjusted net tangible book value to
existing shareholders of $1.88 per Ordinary Share and an immediate dilution of $9.24 per Ordinary Share to new investors participating
in this offering.

<div align='center'>61</div>

The following table shows,
as of June 30, 2024, on a pro forma as adjusted basis, the number of Ordinary Shares purchased from us, the total consideration paid
to us and the average price paid per share by existing shareholders and by new investors purchasing Ordinary Shares in this offering
at an assumed initial public offering price of $11.00 per Ordinary Share, which is the midpoint of the price range set forth on the cover
page of this prospectus, before deducting the estimated underwriting discounts and commissions and estimated offering expenses payable
by us:

|                       |     | Shares 
 Number |           |     | Percent |       |   |